Immunocore Holdings plc (IMCR)

NMS – Real Time Price. Currency in USD

29.30

+0.45 (1.56%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

401M

310M

250M

177M

Cost of goods sold

-8M

-7M

-5M

-8M

Gross Profit

393M

303M

245M

169M

Operating expenses (excl. COGS)

-438M

-374M

-305M

-233M

Operating Income

-45M

-70M

-60M

-64M

Non-operating income, total

26M

18M

-1M

Pretax income

-19M

-53M

-61M

-55M

Equity in earnings

Taxes

-16M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-36M

-51M

-56M

-51M

Immunocore Holdings plc (IMCR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Immunocore Holdings plc (IMCR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Immunocore Holdings plc (IMCR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Immunocore Holdings plc (IMCR)

Income Statement (Annual)

Income Statement (Annual)